Cost-Effectiveness Analysis of Different Sequences of the Use of Epidermal Growth Factor Receptor Inhibitors for Wild-Type KRAS Unresectable Metastatic Colorectal Cancer

Journal of Oncology Practice

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1Wp5ILh
via IFTTT